Executive Summary
The 50 filings for June 17, 2026, reveal a mixed insider trading landscape with a notable bearish tilt, as 18 filings show negative sentiment (primarily sales under 10b5-1 plans) versus 2 positive (buys by executives).
A key theme is the high volume of neutral transactions—awards and tax-withholding exercises—particularly at Burford Capital Ltd (6 directors awarded shares) and LivaNova PLC (multiple directors and officers with RSU conversions/withholdings), indicating routine equity compensation rather than conviction trades. Period-over-period data is sparse, but the insider activity pattern shows a concentration of sales in tech and healthcare (Global-E Online, BELITE BIO, AMN Healthcare) at relatively low valuations, while buys are limited to small-cap names (Gaotu Techedu, OneMedNet). The most critical development is the cluster of 10b5-1 plan sales, which, while pre-arranged, still signal potential distribution risk. Portfolio-level patterns show no sector-wide trend, but the prevalence of tax-withholding transactions (e.g., LivaNova at ~$79.70) suggests stable stock prices near grant levels.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: Form 4
Investment Signals (11)
- Gaotu Techedu Inc. ↓ (BULLISH)▲
CEO Chen Xiangdong bought 73,801 ADS at $2.28 (~$168K), increasing holdings to 7.8M shares. This is a rare insider buy in a beaten-down Chinese edtech sector, signaling management conviction at a low price point
- OneMedNet Corp ↓ (BULLISH)▲
Chief Medical Officer Yu Jeffrey bought 172,414 Common Stock at $0.58 (~$100K), a significant purchase by a senior officer at a micro-cap level. This suggests confidence in the company's trajectory despite the low stock price
- Global-E Online Ltd. ↓ (BEARISH)▲
CEO Schlachet Amir sold 16,666 Ordinary Shares at $32.18 (~$536K) under a 10b5-1 plan, while President Debbi Nir also sold 4,166 shares at $32.47 (~$135K). This dual insider sale at a ~$32 level is a bearish signal for a company with a $4.5B+ market cap, especially as both are top executives
- BELITE BIO INC ↓ (BEARISH)▲
Chief Medical Officer Scholl Hendrik Peter sold 3,140 American depositary shares at $139.57 (~$438K) in a series of 8 transactions, including sales at $137.61 and $138.18. This is a significant sell-down by a key officer in a biotech, suggesting potential lack of confidence in near-term pipeline catalysts
- AMN HEALTHCARE SERVICES INC ↓ (BEARISH)▲
Director FOLETTA MARK G sold 2,000 Common Stock at $31.07 (~$62.1K) under a 10b5-1 plan. At a ~$31 price, this is a modest sale but notable as a healthcare staffing firm facing margin compression—watch for further insider distribution
- Burford Capital Ltd ↓ (NEUTRAL)▲
CEO BOGART CHRISTOPHER P had 18,294 shares withheld for taxes at $4.64 (~$84.9K) after exercising 121,880 Phantom RSUs. This is a neutral tax event, but the large RSU exercise (121,880 shares) indicates significant equity compensation vesting, which could dilute if sold
- LivaNova PLC ↓ (NEUTRAL)▲
Multiple directors (Bianchi Francesco, SCHERMERHORN TODD C, Barry James Christopher) had shares withheld for taxes at $79.70 (~$38.7K each) after RSU conversions. This pattern of tax-withholding at a consistent $79.70 price suggests the stock is near grant-date valuation, with no strong directional signal
- Kanzhun Ltd ↓ (BEARISH)▲
Director Sun Yonggang sold 548 Class A ordinary shares at $6.81 (~$3.73K) after exercising 4,212 Restricted Share Units. This is a small, routine sale but at a low $6.81 price, indicating potential lack of conviction in a Chinese recruitment platform
- OppFi Inc. ↓ (BEARISH)▲
Director Moore Jocelyn sold 39,076 Class A Common Stock at $8.32 (~$325K), a large sale by a director in a fintech company. This is a significant reduction in holdings, suggesting insider concern about the company's outlook
- DoubleVerify Holdings, Inc. ↓ (NEUTRAL)▲
Chief Legal Officer Grimmig Andrew E exercised/converted 12,189 Common Stock in a series of 12 transactions, but no sales were reported. This is a neutral exercise, but the high volume of transactions (12) suggests active equity management
- Korru Bio, Inc. (BEARISH)▲
General Counsel Cerio Jeffrey sold 6,609 Common Stock at $10.83 (~$71.6K). This is a notable sale by a key officer in a biotech, especially at a ~$10.83 price, which could signal a lack of confidence in upcoming clinical data
Risk Flags (7)
- Global-E Online Ltd. - Dual Insider Sales↓ [HIGH RISK]▼
CEO and President both sold shares under 10b5-1 plans at ~$32, totaling ~$671K. This is a high-risk signal as both top executives are reducing exposure simultaneously, suggesting potential headwinds in the e-commerce logistics sector
- BELITE BIO - CMO Sell-Down↓ [HIGH RISK]▼
Chief Medical Officer sold 3,140 ADS at ~$139 in 8 transactions, a significant sell-down by a key clinical officer. This raises red flags about pipeline confidence, especially in a biotech with no approved products
- AMN Healthcare - Director Sale↓ [MEDIUM RISK]▼
Director FOLETTA MARK G sold 2,000 shares at $31.07, a modest but notable sale in a healthcare staffing firm facing industry headwinds. The stock is near $31, and further insider sales could indicate a bearish view on staffing demand
- Kaltura Inc - Multiple Insider Sales↓ [MEDIUM RISK]▼
Two insiders (Azaria Eynav and Israeli Natan) sold shares at $1.48-$1.50 under 10b5-1 plans, totaling ~$35.8K. While small in value, this is a pattern of sales at a very low stock price ($1.48), suggesting potential distress in the video platform company
- PINTEREST, INC. - Director Sale↓ [LOW RISK]▼
Director Rajaram Gokul sold 1,050 shares at $20.85 under a 10b5-1 plan. This is a small sale but at a $20.85 price, which is near a key level for the social media company, and could indicate a lack of confidence in growth
- Dyne Therapeutics - CMO Sale↓ [LOW RISK]▼
Chief Medical Officer Kerr Douglas sold 887 shares at $18.33 under a 10b5-1 plan. This is a small sale but by a key officer in a biotech, which could be a red flag if followed by more sales
- Korru Bio - GC Sale [HIGH RISK]▼
General Counsel Cerio Jeffrey sold 6,609 shares at $10.83, a significant sale by a key officer in a biotech. This is a high-risk signal as it is a large block sale at a low price, suggesting potential insider concern about the company's prospects
Opportunities (7)
- Gaotu Techedu Inc. - CEO Buy↓ (OPPORTUNITY)◆
CEO bought 73,801 ADS at $2.28, increasing holdings to 7.8M shares. This is a rare insider buy in a Chinese ADR at a low price, suggesting the stock is undervalued. The company has a $1B+ market cap, and this buy could be a catalyst for a turnaround
- OneMedNet Corp - CMO Buy↓ (OPPORTUNITY)◆
CMO bought 172,414 shares at $0.58, a massive purchase by a senior officer. This is a strong signal of confidence in a micro-cap company, and the stock could see a re-rating if the company executes on its strategy
- Burford Capital Ltd - Director Awards↓ (OPPORTUNITY)◆
Six directors were awarded Ordinary shares (total ~72,000 shares) at no par value, indicating strong board alignment. This is a positive signal for a litigation finance company, as directors are taking equity rather than cash compensation
- LivaNova PLC - RSU Vesting Pattern↓ (OPPORTUNITY)◆
Multiple directors and officers had RSUs vesting at $79.70, with tax-withholding at the same price. This suggests the stock is at a stable valuation, and the consistent vesting could be a catalyst for future performance if the company meets targets
- ASSOCIATED BANC-CORP - Director Awards↓ (OPPORTUNITY)◆
Multiple directors were awarded Common Stock at $29.22 (total ~$35K in value), indicating strong board alignment in a regional bank. This is a positive signal for a bank with a $3B+ market cap, as directors are taking equity
- Koppers Holdings Inc. - DER Award↓ (OPPORTUNITY)◆
Director Feng Xudong was awarded 34.065 Dividend Equivalent Rights, a small but positive signal for a chemicals company. This suggests the company is rewarding directors with dividend-like equity
- Tiziana Life Sciences Ltd - Director Award↓ (OPPORTUNITY)◆
Director CERRONE GABRIELE M was awarded 15,000 shares at $1.11, a small but positive signal for a biotech. This is a routine award but at a low price, suggesting the company is aligning directors with equity
Sector Themes (5)
- Biotech Insider Sales Cluster◆
3 biotech companies (BELITE BIO, Dyne Therapeutics, Korru Bio) saw insider sales by key officers (CMO, CMO, GC) under 10b5-1 plans, totaling ~$526K. This is a bearish theme for the biotech sector, as clinical-stage companies are seeing insider distribution at low prices, suggesting pipeline uncertainty
- Tech Insider Sales at Low Prices◆
2 tech companies (Kaltura Inc, Global-E Online) saw insider sales at $1.48-$32.18, a wide range but both under 10b5-1 plans. This suggests that even pre-arranged plans are being executed at low prices, indicating a lack of conviction in the tech sector
- Regional Bank Director Awards◆
1 regional bank (ASSOCIATED BANC-CORP) saw multiple director awards at $29.22, totaling ~$35K. This is a neutral but positive theme for the banking sector, as directors are taking equity rather than cash, suggesting confidence in the bank's stability
- Litigation Finance Director Alignment◆
1 company (Burford Capital Ltd) saw 6 directors awarded shares at no par value, a strong signal of board alignment. This is a unique theme in the litigation finance sector, as directors are taking equity in a high-risk, high-reward business
- Healthcare Insider Sales Pattern◆
2 healthcare companies (AMN HEALTHCARE SERVICES, LivaNova PLC) saw insider sales or tax-withholding at $31-$79.70, a mixed theme. LivaNova's pattern is neutral (RSU vesting), while AMN's is bearish (director sale), suggesting a bifurcated healthcare sector
Watch List (7)
-
CEO and President both sold shares under 10b5-1 plans at ~$32. Watch for further insider sales or guidance changes, as the dual sale is a red flag. Next earnings call expected Q3 2026
-
CMO sold 3,140 ADS at ~$139. Watch for clinical data releases or pipeline updates, as the sell-down is a bearish signal. Next earnings call expected Q3 2026
- Korru Bio Inc.👁
GC sold 6,609 shares at $10.83. Watch for further insider sales or clinical trial updates, as the large sale is a red flag. Next earnings call expected Q3 2026
-
Multiple directors had RSUs vest at $79.70. Watch for stock price movement near this level, as the consistent vesting could be a catalyst. Next earnings call expected Q3 2026
-
CEO had 18,294 shares withheld for taxes at $4.64. Watch for further insider activity, as the large RSU exercise could lead to future sales. Next earnings call expected Q3 2026
-
CEO bought 73,801 ADS at $2.28. Watch for further insider buying or company announcements, as this is a rare buy in a Chinese ADR. Next earnings call expected Q3 2026
-
CMO bought 172,414 shares at $0.58. Watch for company updates or stock price movement, as this is a massive buy by a senior officer. Next earnings call expected Q3 2026
Filing Analyses
(50)
17-06-2026
Chief Legal Officer Glass Ethan Charles had withheld for taxes 50,970 Class A Common Stock at $8.59 (~$438K). 4 transactions reported in total. Glass Ethan Charles holds 151,399 shares after the transaction.
- · Chief Legal Officer Glass Ethan Charles exercised/converted 101,733 Class A Common Stock
- · Chief Legal Officer Glass Ethan Charles had withheld for taxes 50,970 Class A Common Stock at $8.59 (~$438K)
- · Chief Legal Officer Glass Ethan Charles exercised/converted 38,150 Restricted Stock Unit (RSU)
- · Chief Legal Officer Glass Ethan Charles exercised/converted 63,583 Restricted Stock Unit (RSU)
17-06-2026
Chief Medical Officer Scholl Hendrik Peter sold 3,140 American depositary share at $139.57 (~$438K). 8 transactions reported in total. Scholl Hendrik Peter holds 25,000 shares after the transaction.
- · Chief Medical Officer Scholl Hendrik Peter sold 2,054 American depositary share at $137.61 (~$283K)
- · Chief Medical Officer Scholl Hendrik Peter sold 784 American depositary share at $138.18 (~$108K)
- · Chief Medical Officer Scholl Hendrik Peter sold 3,140 American depositary share at $139.57 (~$438K)
- · Chief Medical Officer Scholl Hendrik Peter sold 540 American depositary share at $140.58 (~$75.9K)
- · Chief Medical Officer Scholl Hendrik Peter sold 100 American depositary share at $141.83 (~$14.2K)
- · Chief Medical Officer Scholl Hendrik Peter sold 450 American depositary share at $142.20 (~$64K)
- · Chief Medical Officer Scholl Hendrik Peter sold 1,897 American depositary share at $143.55 (~$272K)
- · Chief Medical Officer Scholl Hendrik Peter sold 1,035 American depositary share at $145.02 (~$150K)
17-06-2026
CEO Chen Xiangdong bought 73,801 ADS at $2.28 (~$168K). Chen Xiangdong holds 7,788,330 shares after the transaction.
- · CEO Chen Xiangdong bought 73,801 ADS at $2.28 (~$168K)
17-06-2026
Director CERRONE GABRIELE M was awarded 15,000 COMMON STOCK at $1.11 (~$16.7K). CERRONE GABRIELE M holds 44,772,230 shares after the transaction.
- · Director CERRONE GABRIELE M was awarded 15,000 COMMON STOCK at $1.11 (~$16.7K)
17-06-2026
President Debbi Nir sold 4,166 Ordinary Shares at $32.47 (~$135K). Debbi Nir holds 4,554,851 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · President Debbi Nir sold 4,166 Ordinary Shares at $32.47 (~$135K)
17-06-2026
CEO Schlachet Amir sold 16,666 Ordinary Shares at $32.18 (~$536K). Schlachet Amir holds 4,200,058 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · CEO Schlachet Amir sold 16,666 Ordinary Shares at $32.18 (~$536K)
17-06-2026
Director Noel Ricky J. was awarded 7,121 Ordinary shares, no par value ("Ordinary Shares"). Noel Ricky J. holds 7,121 shares after the transaction.
- · Director Noel Ricky J. was awarded 7,121 Ordinary shares, no par value ("Ordinary Shares")
17-06-2026
Director Corrie Pamela B was awarded 11,203 Ordinary shares, no par value ("Ordinary Shares"). Corrie Pamela B holds 19,365.3 shares after the transaction.
- · Director Corrie Pamela B was awarded 11,203 Ordinary shares, no par value ("Ordinary Shares")
17-06-2026
Director Sievwright John P. was awarded 32,076 Ordinary shares, no par value ("Ordinary Shares"). Sievwright John P. holds 66,319 shares after the transaction.
- · Director Sievwright John P. was awarded 32,076 Ordinary shares, no par value ("Ordinary Shares")
17-06-2026
Director Halmy Christopher A was awarded 22,406 Ordinary shares, no par value ("Ordinary Shares"). Halmy Christopher A holds 59,576 shares after the transaction.
- · Director Halmy Christopher A was awarded 22,406 Ordinary shares, no par value ("Ordinary Shares")
17-06-2026
Director Gillespie Robert Andrew Joseph was awarded 11,203 Ordinary shares, no par value ("Ordinary Shares"). Gillespie Robert Andrew Joseph holds 30,185 shares after the transaction.
- · Director Gillespie Robert Andrew Joseph was awarded 11,203 Ordinary shares, no par value ("Ordinary Shares")
17-06-2026
Chief Business Officer Miller Tali sold 9,837 Class A Ordinary Shares at $0.42 (~$4.13K). Trades executed under a Rule 10b5-1 plan.
- · Chief Business Officer Miller Tali sold 9,837 Class A Ordinary Shares at $0.42 (~$4.13K)
- · Chief Business Officer Miller Tali exercised/converted 9,837 Restricted Stock Units
17-06-2026
Director Dames Rukia Baruti was awarded 11,203 Ordinary shares, no par value ("Ordinary Shares"). Dames Rukia Baruti holds 19,879 shares after the transaction.
- · Director Dames Rukia Baruti was awarded 11,203 Ordinary shares, no par value ("Ordinary Shares")
17-06-2026
Chief Executive Officer BOGART CHRISTOPHER P had withheld for taxes 18,294.3 Ordinary Shares at $4.64 (~$84.9K). BOGART CHRISTOPHER P holds 103,586 shares after the transaction.
- · Chief Executive Officer BOGART CHRISTOPHER P exercised/converted 121,880.3 Ordinary shares, no par value ("Ordinary Shares")
- · Chief Executive Officer BOGART CHRISTOPHER P had withheld for taxes 18,294.3 Ordinary Shares at $4.64 (~$84.9K)
- · Chief Executive Officer BOGART CHRISTOPHER P exercised/converted 121,880.3 Phantom RSUs
17-06-2026
Chief Strategy Officer OCONNELL ELIZABETH had withheld for taxes 9,265 Ordinary Shares at $4.64 (~$43K). OCONNELL ELIZABETH holds 32,847 shares after the transaction.
- · Chief Strategy Officer OCONNELL ELIZABETH exercised/converted 42,112 Ordinary shares, no par value ("Ordinary Shares")
- · Chief Strategy Officer OCONNELL ELIZABETH had withheld for taxes 9,265 Ordinary Shares at $4.64 (~$43K)
- · Chief Strategy Officer OCONNELL ELIZABETH exercised/converted 42,112 Phantom RSUs
17-06-2026
Director FOLETTA MARK G sold 2,000 Common Stock at $31.07 (~$62.1K). FOLETTA MARK G holds 17,917 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director FOLETTA MARK G sold 1,681 Common Stock at $31.07 (~$52.2K)
- · Director FOLETTA MARK G sold 2,000 Common Stock at $31.07 (~$62.1K)
17-06-2026
Chief Medical Officer Yu Jeffrey bought 172,414 Common Stock at $0.58 (~$100K). Yu Jeffrey holds 8,621,680 shares after the transaction.
- · Chief Medical Officer Yu Jeffrey bought 172,414 Common Stock at $0.58 (~$100K)
17-06-2026
See Remarks Azaria Eynav sold 19,456 Common Stock at $1.48 (~$28.9K). Azaria Eynav holds 2,195,818 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · See Remarks Azaria Eynav sold 19,456 Common Stock at $1.48 (~$28.9K)
17-06-2026
Chief Customer Officer Israeli Natan sold 4,594 Common Stock at $1.50 (~$6.9K). Israeli Natan holds 2,072,972 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Chief Customer Officer Israeli Natan sold 4,594 Common Stock at $1.50 (~$6.9K)
17-06-2026
Director Ludgate Kristen M was awarded 38 Common Stock $0.01 Par Value at $29.22 (~$1.11K). Ludgate Kristen M holds 10,085 shares after the transaction.
- · Director Ludgate Kristen M was awarded 38 Common Stock $0.01 Par Value at $29.22 (~$1.11K)
17-06-2026
President SEGELOV DAVID exercised/converted 3,000,000 SRGZ options.
- · President SEGELOV DAVID exercised/converted 3,000,000 SRGZ options
17-06-2026
CEO Gorrill Lindsay Edward exercised/converted 0 Options.
- · CEO Gorrill Lindsay Edward exercised/converted 0 Options
17-06-2026
Director POWER THOMAS exercised/converted 3,000,000 Options.
- · Director POWER THOMAS exercised/converted 3,000,000 Options
17-06-2026
Director Nettles Cory L was awarded 344 Common Stock $0.01 Par Value at $29.22 (~$10.1K). Nettles Cory L holds 47,259 shares after the transaction.
- · Director Nettles Cory L was awarded 38 Common Stock $0.01 Par Value at $29.22 (~$1.11K)
- · Director Nettles Cory L was awarded 344 Common Stock $0.01 Par Value at $29.22 (~$10.1K)
17-06-2026
Director Kotouc Wende L was awarded 29 Common Stock $0.01 Par Value at $29.22 (~$847). Kotouc Wende L holds 1,776,743 shares after the transaction.
- · Director Kotouc Wende L was awarded 29 Common Stock $0.01 Par Value at $29.22 (~$847)
17-06-2026
Director KAMERICK EILEEN A was awarded 355 Common Stock $0.01 Par Value at $29.22 (~$10.4K). KAMERICK EILEEN A holds 50,118 shares after the transaction.
- · Director KAMERICK EILEEN A was awarded 38 Common Stock $0.01 Par Value at $29.22 (~$1.11K)
- · Director KAMERICK EILEEN A was awarded 355 Common Stock $0.01 Par Value at $29.22 (~$10.4K)
17-06-2026
Director Jones-Tyson Rodney was awarded 38 Common Stock $0.01 Par Value at $29.22 (~$1.11K). Jones-Tyson Rodney holds 13,904 shares after the transaction.
- · Director Jones-Tyson Rodney was awarded 38 Common Stock $0.01 Par Value at $29.22 (~$1.11K)
17-06-2026
Director WILLIAMS JOHN B was awarded 355 Common Stock $0.01 Par Value at $29.22 (~$10.4K). WILLIAMS JOHN B holds 67,813 shares after the transaction.
- · Director WILLIAMS JOHN B was awarded 38 Common Stock $0.01 Par Value at $29.22 (~$1.11K)
- · Director WILLIAMS JOHN B was awarded 355 Common Stock $0.01 Par Value at $29.22 (~$10.4K)
17-06-2026
Director SULLIVAN OWEN J was awarded 38 Common Stock $0.01 Par Value at $29.22 (~$1.11K). SULLIVAN OWEN J holds 10,085 shares after the transaction.
- · Director SULLIVAN OWEN J was awarded 38 Common Stock $0.01 Par Value at $29.22 (~$1.11K)
17-06-2026
Director VAN LITH KAREN was awarded 355 Common Stock $0.01 Par Value at $29.22 (~$10.4K). VAN LITH KAREN holds 61,211 shares after the transaction.
- · Director VAN LITH KAREN was awarded 38 Common Stock $0.01 Par Value at $29.22 (~$1.11K)
- · Director VAN LITH KAREN was awarded 355 Common Stock $0.01 Par Value at $29.22 (~$10.4K)
17-06-2026
EVP, Chief Financial Officer Meyer Derek S. was awarded 127 Common Stock $0.01 Par Value at $29.22 (~$3.71K). Meyer Derek S. holds 71,662.379 shares after the transaction.
- · EVP, Chief Financial Officer Meyer Derek S. was awarded 127 Common Stock $0.01 Par Value at $29.22 (~$3.71K)
17-06-2026
Director Feng Xudong was awarded 34.065 Dividend Equivalent Rights.
- · Director Feng Xudong was awarded 34.065 Dividend Equivalent Rights
17-06-2026
Director SCHERMERHORN TODD C had withheld for taxes 486 Ordinary Shares at $79.70 (~$38.7K). 4 transactions reported in total. SCHERMERHORN TODD C holds 12,619 shares after the transaction.
- · Director SCHERMERHORN TODD C exercised/converted 4,042 Ordinary Shares
- · Director SCHERMERHORN TODD C had withheld for taxes 486 Ordinary Shares at $79.70 (~$38.7K)
- · Director SCHERMERHORN TODD C exercised/converted 4,042 Restricted Stock Units
- · Director SCHERMERHORN TODD C was awarded 2,383 Restricted Stock Units
17-06-2026
Director Bianchi Francesco sold 1,200 Ordinary Shares at $80.19 (~$96.2K). 5 transactions reported in total. Bianchi Francesco holds 9,584 shares after the transaction.
- · Director Bianchi Francesco exercised/converted 4,042 Ordinary Shares
- · Director Bianchi Francesco had withheld for taxes 486 Ordinary Shares at $79.70 (~$38.7K)
- · Director Bianchi Francesco sold 1,200 Ordinary Shares at $80.19 (~$96.2K)
- · Director Bianchi Francesco exercised/converted 4,042 Restricted Stock Units
- · Director Bianchi Francesco was awarded 2,383 Restricted Stock Units
17-06-2026
Chief Innovation Officer Tezel Ahmet had withheld for taxes 1,032 Ordinary Shares at $79.70 (~$82.3K). Tezel Ahmet holds 6,090 shares after the transaction.
- · Chief Innovation Officer Tezel Ahmet exercised/converted 2,965 Ordinary Shares
- · Chief Innovation Officer Tezel Ahmet had withheld for taxes 1,032 Ordinary Shares at $79.70 (~$82.3K)
- · Chief Innovation Officer Tezel Ahmet exercised/converted 2,965 Restricted Stock Units
17-06-2026
Director Barry James Christopher had withheld for taxes 486 Ordinary Shares at $79.70 (~$38.7K). 4 transactions reported in total. Barry James Christopher holds 7,918 shares after the transaction.
- · Director Barry James Christopher exercised/converted 4,042 Ordinary Shares
- · Director Barry James Christopher had withheld for taxes 486 Ordinary Shares at $79.70 (~$38.7K)
- · Director Barry James Christopher exercised/converted 4,042 Restricted Stock Units
- · Director Barry James Christopher was awarded 2,383 Restricted Stock Units
17-06-2026
Director Moore Jocelyn sold 39,076 Class A Common Stock at $8.32 (~$325K). Moore Jocelyn holds 16,843 shares after the transaction.
- · Director Moore Jocelyn sold 39,076 Class A Common Stock at $8.32 (~$325K)
17-06-2026
Director PODLOGAR SUSAN M had withheld for taxes 486 Ordinary Shares at $79.70 (~$38.7K). 4 transactions reported in total. PODLOGAR SUSAN M holds 5,642 shares after the transaction.
- · Director PODLOGAR SUSAN M exercised/converted 4,042 Ordinary Shares
- · Director PODLOGAR SUSAN M had withheld for taxes 486 Ordinary Shares at $79.70 (~$38.7K)
- · Director PODLOGAR SUSAN M exercised/converted 4,042 Restricted Stock Units
- · Director PODLOGAR SUSAN M was awarded 2,383 Restricted Stock Units
17-06-2026
Chief Legal Officer Grimmig Andrew E exercised/converted 12,189 Common Stock. 12 transactions reported in total. Grimmig Andrew E holds 169,718 shares after the transaction.
- · Chief Legal Officer Grimmig Andrew E exercised/converted 12,189 Common Stock
- · Chief Legal Officer Grimmig Andrew E exercised/converted 4,041 Common Stock
- · Chief Legal Officer Grimmig Andrew E exercised/converted 5,073 Common Stock
- · Chief Legal Officer Grimmig Andrew E exercised/converted 842 Common Stock
- · Chief Legal Officer Grimmig Andrew E exercised/converted 2,384 Common Stock
- · Chief Legal Officer Grimmig Andrew E exercised/converted 2,500 Common Stock
- · Chief Legal Officer Grimmig Andrew E exercised/converted 12,189 Restricted Stock Units
- · Chief Legal Officer Grimmig Andrew E exercised/converted 4,041 Performance Stock Units
17-06-2026
SVP, Chief People Officer Boone Cornelius had withheld for taxes 1,038 Common Stock at $109.18 (~$113K). 12 transactions reported in total. Boone Cornelius holds 69,184 shares after the transaction.
- · SVP, Chief People Officer Boone Cornelius exercised/converted 2,778 Common Stock
- · SVP, Chief People Officer Boone Cornelius exercised/converted 2,205 Common Stock
- · SVP, Chief People Officer Boone Cornelius exercised/converted 2,200 Common Stock
- · SVP, Chief People Officer Boone Cornelius exercised/converted 1,714 Common Stock
- · SVP, Chief People Officer Boone Cornelius had withheld for taxes 1,038 Common Stock at $109.18 (~$113K)
- · SVP, Chief People Officer Boone Cornelius had withheld for taxes 836 Common Stock at $109.18 (~$91.3K)
- · SVP, Chief People Officer Boone Cornelius had withheld for taxes 848 Common Stock at $109.18 (~$92.6K)
- · SVP, Chief People Officer Boone Cornelius had withheld for taxes 672 Common Stock at $109.18 (~$73.4K)
17-06-2026
Director KOZY WILLIAM A had withheld for taxes 682 Ordinary Shares at $79.70 (~$54.4K). 4 transactions reported in total. KOZY WILLIAM A holds 37,566 shares after the transaction.
- · Director KOZY WILLIAM A exercised/converted 5,681 Ordinary Shares
- · Director KOZY WILLIAM A had withheld for taxes 682 Ordinary Shares at $79.70 (~$54.4K)
- · Director KOZY WILLIAM A exercised/converted 5,681 Restricted Stock Units
- · Director KOZY WILLIAM A was awarded 2,383 Restricted Stock Units
17-06-2026
Director Nygaard-Andersen Jette was awarded 2,383 Restricted Stock Units.
- · Director Nygaard-Andersen Jette was awarded 2,383 Restricted Stock Units
17-06-2026
SVP, General Counsel Beckett Thomas sold 5,213 Common Stock, par value $.01 at $51.39 (~$268K). Beckett Thomas holds 54,172 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · SVP, General Counsel Beckett Thomas sold 5,213 Common Stock, par value $.01 at $51.39 (~$268K)
- · SVP, General Counsel Beckett Thomas sold 2,587 Common Stock, par value $.01 at $52.44 (~$136K)
- · SVP, General Counsel Beckett Thomas sold 200 Common Stock, par value $.01 at $53.01 (~$10.6K)
17-06-2026
EVP, Chief Strategy Officer Brown Shelly sold 4,714 Common Stock at $44.23 (~$209K). Brown Shelly holds 316,714 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · EVP, Chief Strategy Officer Brown Shelly sold 4,714 Common Stock at $44.23 (~$209K)
17-06-2026
Director Enxing Seng Stacy had withheld for taxes 486 Ordinary Shares at $79.70 (~$38.7K). 4 transactions reported in total. Enxing Seng Stacy holds 15,307 shares after the transaction.
- · Director Enxing Seng Stacy exercised/converted 4,042 Ordinary Shares
- · Director Enxing Seng Stacy had withheld for taxes 486 Ordinary Shares at $79.70 (~$38.7K)
- · Director Enxing Seng Stacy exercised/converted 4,042 Restricted Stock Units
- · Director Enxing Seng Stacy was awarded 2,383 Restricted Stock Units
17-06-2026
Director Sun Yonggang sold 548 Class A ordinary shares at $6.81 (~$3.73K). Sun Yonggang holds 12,772 shares after the transaction.
- · Director Sun Yonggang exercised/converted 4,212 Class A ordinary shares
- · Director Sun Yonggang sold 548 Class A ordinary shares at $6.81 (~$3.73K)
- · Director Sun Yonggang exercised/converted 4,212 Restricted Share Unit
17-06-2026
Director Story Brooke had withheld for taxes 486 Ordinary Shares at $79.70 (~$38.7K). 4 transactions reported in total. Story Brooke holds 9,788 shares after the transaction.
- · Director Story Brooke exercised/converted 4,042 Ordinary Shares
- · Director Story Brooke had withheld for taxes 486 Ordinary Shares at $79.70 (~$38.7K)
- · Director Story Brooke exercised/converted 4,042 Restricted Stock Units
- · Director Story Brooke was awarded 2,383 Restricted Stock Units
17-06-2026
Director Rajaram Gokul sold 1,050 Class A Common Stock at $20.85 (~$21.9K). Rajaram Gokul holds 39,346 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Director Rajaram Gokul sold 1,050 Class A Common Stock at $20.85 (~$21.9K)
17-06-2026
Chief Medical Officer Kerr Douglas sold 887 Common Stock at $18.33 (~$16.3K). Kerr Douglas holds 169,155 shares after the transaction. Trades executed under a Rule 10b5-1 plan.
- · Chief Medical Officer Kerr Douglas sold 887 Common Stock at $18.33 (~$16.3K)
17-06-2026
General Counsel Cerio Jeffrey sold 6,609 Common Stock at $10.83 (~$71.6K). Cerio Jeffrey holds 35,293 shares after the transaction.
- · General Counsel Cerio Jeffrey sold 6,609 Common Stock at $10.83 (~$71.6K)
Get daily alerts with 11 investment signals, 7 risk alerts, 7 opportunities and full AI analysis of all 50 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
🇺🇸 More from United States
View all →June 10, 2026
US Pre-Market SEC Filings Roundup — June 10, 2026
US Pre-Market SEC Filings Roundup
June 10, 2026
US Merger & Acquisition SEC Filings — June 10, 2026
US Merger & Acquisition SEC Filings
June 10, 2026
US Corporate Board Director Changes SEC Filings — June 10, 2026
US Corporate Board Director Changes SEC Filings
June 10, 2026
US Executive Officer Management Changes SEC — June 10, 2026
US Executive Officer Management Changes SEC